New York Life Investment Management’s Vigil Neuroscience VIGL Stock Holding History

New York Life Investment Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-53,069	Closed	-$422K	–	841
2025 Q2	$422K	Buy	+53,069	New	+$238K	﹤0.01%	775

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

New York Life Investment Management's VIGL Position: Q3 2025 in Review

New York Life Investment Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 53,069 shares — an estimated $422K sold.

New York Life Investment Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $422K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

New York Life Investment Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
New York Life Investment Management sold 53,069 Vigil Neuroscience shares in Q3 2025, an estimated $422K.
New York Life Investment Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
New York Life Investment Management's Vigil Neuroscience position peaked at $422K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on New York Life Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.